Polynovo Limited Is An Australian Company Focused On Developing Innovative Medical Devicesparticularly In The Medical And Surgical Equipment Manufacturing Industrylisted On The Australian Securities Exchange Under The Code Pnvpolynovo Aims To Improve Patient Outcomes Through Its Disruptive Technologies The Company Specializes In Products That Manage Acute Complex Woundsutilizing Its Patented Bioabsorbable Polymer Technology Called Novosorbone Of Its Key Offerings Is Novosorb Btmbiodegradable Temporizing Matrix Which Received Fda Clearance In 2015 And Is Used For Treating Full Thickness Burnsanother Productsuprathelis Part Of Their Wound Management Portfoliopolynovo S Products Have Been Used To Treat Over 50 000 Patients In 41 Countrieshighlighting Its Leadership In Burn Procedures And Expansion Into Trauma And Limb Salvage Under The Leadership Of Ceo Bruce Rathiepolynovo Is Expanding Its Manufacturing Capabilities To Support Future Growththe Company Reported Total Revenue Of Approximately $104 8 Million In 2024Reflecting Its Increasing Market Presence And Product Adoptionpolynovo Adheres To High Standards Of Corporate Governance And Maintains Certifications For Quality Assurance
No conferences found for this company.
| Company Name | Polynovo Biomaterials Pty Ltd |
| Country |
Australia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
